Imaging Studies in Corticobasal Syndrome

Description

The primary goal of this study is to investigate inflammation and white matter damage in corticobasal syndrome and determine whether these processes are related to each other. We will address our goal by using neuroimaging and blood plasma biomarkers, as well as molecular pathology.

Conditions

Cortico Basal Degeneration, Corticobasal Syndrome, Corticobasal Syndrome(CBS), Corticobasal Degeneration, Corticobasal Degeneration (CBD), Corticobasal Syndrome (CBS)

Study Overview

Study Details

Study overview

The primary goal of this study is to investigate inflammation and white matter damage in corticobasal syndrome and determine whether these processes are related to each other. We will address our goal by using neuroimaging and blood plasma biomarkers, as well as molecular pathology.

Neuroinflammation, White Matter Integrity, AD Biomarkers and Pathology in Corticobasal Syndrome

Imaging Studies in Corticobasal Syndrome

Condition
Cortico Basal Degeneration
Intervention / Treatment

-

Contacts and Locations

Rochester

Mayo Clinic, Rochester, Minnesota, United States, 55905

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Actively taking daily anti-inflammatory medications (NSAIDs, corticosteriods, etc) except for a small control group. Anti-inflammatory creams, eye drops and nasal sprays are not exclusions.
  • 2. Generalized inflammatory condition and treatment with immunosuppressive, corticoid/glucocorticoid, steroidal or non-steroidal anti-inflammatory medication within 2 weeks of scanning

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Jennifer Whitwell,

Jennifer Whitwell, Ph.D., PRINCIPAL_INVESTIGATOR, Mayo Clinic

Study Record Dates

2031-03-30